BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17721656)

  • 1. Clearance of recurrent, classical Kaposi's sarcoma using multiple paclitaxel treatments.
    Osawa R; Kato N; Yanagi T; Yamane N
    Acta Derm Venereol; 2007; 87(5):435-6. PubMed ID: 17721656
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy.
    Baskan EB; Tunali S; Adim SB; Kiyici M; Ali R
    Int J Dermatol; 2006 Dec; 45(12):1441-3. PubMed ID: 17184252
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of classical type Kaposi's sarcoma with paclitaxel.
    Chao SC; Lee JY; Tsao CJ
    Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel for AIDS-associated Kaposi's sarcoma.
    Dhillon T; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
    Hsu CH; Chen MY; Cheng AL
    Anticancer Res; 2000; 20(2B):1159-61. PubMed ID: 10810414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant Kaposi's sarcoma treated with paclitaxel.
    Wu CJ; Scadden DT
    J Clin Oncol; 1998 Oct; 16(10):3478-9. PubMed ID: 9779728
    [No Abstract]   [Full Text] [Related]  

  • 7. Paclitaxel for relapsed or recurrent HIV-associated pediatric Kaposi's sarcoma.
    Reddy-Holdcraft S; Mehta PS; Agrawal AK
    AIDS; 2014 Mar; 28(5):800-2. PubMed ID: 24983546
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma.
    Silvestris N; Galetta D; Colucci G
    Anticancer Res; 2009 Feb; 29(2):675-6. PubMed ID: 19331220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad activist support for paclitaxel as second-line treatment for Kaposi's sarcoma.
    AIDS Patient Care STDS; 1997 Oct; 11(5):375-7. PubMed ID: 11361827
    [No Abstract]   [Full Text] [Related]  

  • 10. European Committee signs off on Paxene for Kaposi's sarcoma treatment.
    Oncologist; 1999; 4(2):187. PubMed ID: 10337389
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of classical Kaposi's sarcoma with visceral involvement by weekly paclitaxel.
    Engin H; Celik I
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):178. PubMed ID: 12069127
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-cancer agents. A new treatment for Kaposi's sarcoma?
    TreatmentUpdate; 2002; 14(7):6-8. PubMed ID: 12400501
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of relapsed visceral Kaposi's sarcoma with bilateral chylothoraces successfully treated with paclitaxel.
    Natarajan P; Miller A
    Int J STD AIDS; 2015 Jul; 26(8):605-9. PubMed ID: 25122577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
    Zidan J; Robenstein W; Abzah A; Taman S
    Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
    Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
    J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection.
    Fardet L; Stoebner PE; Bachelez H; Descamps V; Kerob D; Meunier L; Dandurand M; Morel P; Lebbe C
    Cancer; 2006 Apr; 106(8):1785-9. PubMed ID: 16534786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel for treating KS.
    Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment.
    Guenova E; Metzler G; Hoetzenecker W; Berneburg M; Rocken M
    Arch Dermatol; 2008 May; 144(5):692-3. PubMed ID: 18490609
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of docetaxel in disseminated classical Kaposi's sarcoma.
    Stoebner PE; Nocera T; Meynadier J; Meunier L
    Br J Dermatol; 2000 Dec; 143(6):1357-9. PubMed ID: 11122073
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of paclitaxel in the treatment of Kaposi sarcoma.
    Ercolak V; Sahin B; Gunaldi M; Duman BB; Afsar CU
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4095-100. PubMed ID: 26592833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.